#USA #New York #agentic AI #Aily Labs #Amy Chang

Aily Labs Strengthens Leadership to Propel AI Integration in Fortune 500 Companies

In a bold move to accelerate the adoption of Agentic AI within Fortune 500 organizations, Aily Labs has announced key appointments to its board of directors and advisory board. The inclusion of industry heavyweights Amy Chang, Joseph Jimenez, and Derica Rice marks a pivotal moment for the company as it seeks to enhance its innovative platform for decision intelligence on a global scale.

Welcoming Amy Chang to the Board

Amy Chang, known for her strategic acumen in digital transformation, joins the Aily Labs board and advisory board. Currently a board member at Disney and Procter & Gamble, Chang brings extensive experience in technology scaling and product innovation. She previously founded Accompany, Inc., which was acquired by Cisco, where she thereafter led a billion-dollar business unit. Her reputation as a visionary leader aligns perfectly with Aily Labs' mission to redefine the way businesses utilize AI to enhance decision-making processes.

Chang expressed her enthusiasm for joining Aily Labs, highlighting the company's position at the forefront of the AI revolution. "The vision of Aily Labs to guide organizations from passive data to proactive, agent-based actions is bold, and I am thrilled to be part of this journey in shaping the future of work with Agentic AI," she noted.

Joseph Jimenez Brings Critical Healthcare Expertise

Joseph Jimenez, co-founder and managing director at Aditum Bio, is another pivotal figure joining Aily Labs' advisory board. With decades of experience as a leader in the healthcare sector, Jimenez's insight into strategic growth and decision-making will prove invaluable as the company expands its influence within various industries. Formerly the CEO of Novartis, he has a track record of making capital allocation decisions that enhance efficiency and drive results.

Jimenez emphasized the importance of speed and precision in the pharmaceutical landscape, asserting, "Aily Labs applies the same urgency and accuracy to corporate decision-making with agent-based AI, delivering faster, smarter outcomes that every leadership team needs."

Derica Rice to Foster AI in Multiple Sectors

Derica Rice, the former EVP of CVS Health and President of CVS Caremark, joins Aily Labs to further the integration of AI in healthcare, consumer goods, and retail sectors. His extensive experience in both finance and healthcare makes him an excellent addition to the team. Previously serving as CFO at Eli Lilly, Rice has been instrumental in shaping corporate strategies that emphasize efficiency and performance.

Rice shared his excitement about Aily Labs' mission, stating, "The company unlocks a new dimension of corporate productivity by enabling seamless collaboration between humans and AI agents, eliminating inefficiencies and allowing for precise actions. I look forward to supporting the spread of AI-driven decision intelligence across various sectors."

The Vision of Aily Labs

Aily Labs is dedicated to transforming corporate requirements into actionable AI applications seamlessly integrated into user-friendly platforms. Their AI-powered suite leverages cutting-edge advancements in large language models and business data, aiming to equip companies with real-time insights and actionable data that drive efficiency and innovation.

Since its establishment in 2020, Aily Labs has been on a mission to revolutionize the way businesses leverage AI, enabling them to thrive in an increasingly digital landscape. The new board appointments signal a robust commitment to propelling this vision forward, aiming to redefine decision-making standards in Fortune 500 companies and beyond.

For more details on Aily Labs, please visit ailylabs.com.